Pacira Pharm Inc
(PCRX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2009 | 12-2008 | 12-2006 | |
| Sales | 15,006 | 13,925 | 0 |
| Cost of Goods | 12,301 | 17,463 | N/A |
| Gross Profit | 2,705 | -3,538 | N/A |
| Operating Expenses | 31,554 | 42,288 | 0 |
| Operating Income | -28,548 | -45,363 | N/A |
| Interest Expense | 1,723 | 0 | 0 |
| Other Income | -1,436 | 3,501 | 0 |
| Pre-tax Income | -31,707 | -41,862 | 0 |
| Net Income Continuous | -31,707 | -41,862 | N/A |
| Net Income | $-31,707 | $-41,862 | $N/A |
| EPS Basic Total Ops | -55.32 | -79.23 | N/A |
| EPS Basic Continuous Ops | -55.32 | -79.23 | N/A |
| EPS Diluted Total Ops | -55.32 | -79.23 | N/A |
| EPS Diluted Continuous Ops | -55.32 | -79.23 | N/A |
| EBITDA(a) | $-24,116 | $-41,532 | $N/A |